Macrophage migration inhibitory factor is elevated in obese adolescents

Uran Kamchybekov1, Hans R Figulla, Norbert Gerdes

  • 1Friedrich-Schiller-University, Clinic of Internal Medicine I, Jena, Germany.

Abstract

Insights

Obese adolescents exhibit elevated levels of macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine. This finding suggests a link between childhood obesity, inflammation, and potential health complications.

Area of Science:

  • Pediatric Endocrinology
  • Immunology
  • Metabolic Disorders

Background:

  • Childhood and adolescent obesity prevalence is increasing globally.
  • Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine involved in immune responses.
  • Understanding inflammatory markers in pediatric obesity is crucial for managing associated health risks.

Purpose of the Study:

  • To investigate the role and levels of macrophage migration inhibitory factor (MIF) in overweight adolescents.
  • To explore the association between MIF concentrations and markers of inflammation and obesity in this population.

Main Methods:

  • A cohort of 79 male adolescents was studied.
  • Participants were classified as overweight based on age-specific waist circumference (90th percentile).
  • Macrophage migration inhibitory factor (MIF) levels were quantified using multiplex immune-assay technology.

Main Results:

  • Overweight adolescents presented with elevated systolic blood pressure and C-reactive protein (CRP) levels.
  • Significantly higher circulating MIF concentrations were observed in overweight adolescents compared to controls (p = 0.003).
  • Increased MIF levels correlated with heightened markers of inflammation and obesity.

Conclusions:

  • Elevated macrophage migration inhibitory factor (MIF) levels are evident in obese adolescents.
  • These findings indicate the presence of low-grade inflammation in overweight youth.
  • Elevated MIF may represent a key link between adolescent obesity and its related co-morbidities.